<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34696427</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>10</Issue><PubDate><Year>2021</Year><Month>Oct</Month><Day>04</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Pericarditis after SARS-CoV-2 Infection: Another Pebble in the Mosaic of Long COVID?</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1997</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v13101997</ELocationID><Abstract><AbstractText>With the emerging success of the COVID-19 vaccination programs, the incidence of acute COVID-19 will decrease. However, given the high number of people who contracted SARS-CoV-2 infection and recovered, we will be faced with a significant number of patients with persistent symptoms even months after their COVID-19 infection. In this setting, long COVID and its cardiovascular manifestations, including pericarditis, need to become a top priority for healthcare systems as a new chronic disease process. Concerning the relationship between COVID-19 and pericardial diseases, pericarditis appears to be common in the acute infection but rare in the postacute period, while small pericardial effusions may be relatively common in the postacute period of COVID-19. Here, we reported a series of 7 patients developing pericarditis after a median of 20 days from clinical and virological recovery from SARS-CoV-2 infection. We excluded specific identifiable causes of pericarditis, hence we speculate that these cases can be contextualized within the clinical spectrum of long COVID. All our patients were treated with a combination of colchicine and either ASA or NSAIDs, but four of them did not achieve a clinical response. When switched to glucocorticoids, these four patients recovered with no recurrence during drug tapering. Based on this observation and on the latency of pericarditis occurrence (a median of 20 days after a negative nasopharyngeal swab), could be suggested that post-COVID pericarditis may be linked to ongoing inflammation sustained by the persistence of viral nucleic acid without virus replication in the pericardium. Therefore, glucocorticoids may be a suitable treatment option in patients not responding or intolerant to conventional therapy and who require to counteract the pericardial inflammatory component rather than direct an acute viral injury to the pericardial tissue.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Carubbi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-1958-5136</Identifier><AffiliationInfo><Affiliation>Internal Medicine and Nephrology Unit, Department of Life, Health &amp; Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, ASL 1 Avezzano-Sulmona-L'Aquila, San Salvatore Hospital, 67100 L'Aquila, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alunno</LastName><ForeName>Alessia</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1105-5640</Identifier><AffiliationInfo><Affiliation>Internal Medicine and Nephrology Unit, Department of Life, Health &amp; Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leone</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Internal Medicine and Nephrology Unit, Department of Life, Health &amp; Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Gregorio</LastName><ForeName>Nicoletta</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Internal Medicine and Nephrology Unit, Department of Life, Health &amp; Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, ASL 1 Avezzano-Sulmona-L'Aquila, San Salvatore Hospital, 67100 L'Aquila, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mancini</LastName><ForeName>Bernardina</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Internal Medicine and Nephrology Unit, Department of Life, Health &amp; Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, ASL 1 Avezzano-Sulmona-L'Aquila, San Salvatore Hospital, 67100 L'Aquila, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viscido</LastName><ForeName>Angelo</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8513-3758</Identifier><AffiliationInfo><Affiliation>Internal Medicine and Nephrology Unit, Department of Life, Health &amp; Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Pinto</LastName><ForeName>Rita</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-4058-0655</Identifier><AffiliationInfo><Affiliation>Internal Medicine and Nephrology Unit, Department of Life, Health &amp; Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cicogna</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, ASL 1 Avezzano-Sulmona-L'Aquila, San Salvatore Hospital, 67100 L'Aquila, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiology and Coronary Care Unit, San Salvatore Hospital, 67100 L'Aquila, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grassi</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Internal Medicine and Nephrology Unit, Department of Life, Health &amp; Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferri</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Internal Medicine and Nephrology Unit, Department of Life, Health &amp; Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000894">Anti-Inflammatory Agents, Non-Steroidal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005938">Glucocorticoids</NameOfSubstance></Chemical><Chemical><RegistryNumber>SML2Y3J35T</RegistryNumber><NameOfSubstance UI="D003078">Colchicine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000894" MajorTopicYN="N">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003078" MajorTopicYN="N">Colchicine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005938" MajorTopicYN="N">Glucocorticoids</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010490" MajorTopicYN="N">Pericardial Effusion</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010493" MajorTopicYN="N">Pericarditis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010496" MajorTopicYN="N">Pericardium</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="N">COVID-19 Drug Treatment</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">pericarditis</Keyword></KeywordList><CoiStatement>All authors have nothing to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>10</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34696427</ArticleId><ArticleId IdType="pmc">PMC8540566</ArticleId><ArticleId IdType="doi">10.3390/v13101997</ArticleId><ArticleId IdType="pii">v13101997</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wong C.K., Wong J.Y., Tang E.H., Au C.H., Wai A.K. Clinical presentations, laboratory and radiological findings, and treatments for 11,028 COVID-19 patients: A systematic review and meta-analysis. Sci. Rep. 2020;10:19765. doi: 10.1038/s41598-020-74988-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-74988-9</ArticleId><ArticleId IdType="pmc">PMC7666204</ArticleId><ArticleId IdType="pubmed">33188232</ArticleId></ArticleIdList></Reference><Reference><Citation>Alunno A., Najm A., Machado P.M., Bertheussen H., Burmester G.R., Carubbi F., De Marco G., Giacomelli R., Hermine O., Isaacs J.D., et al. EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19. Ann. Rheum. Dis. 2021;80:698&#x2013;706. doi: 10.1136/annrheumdis-2020-219724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-219724</ArticleId><ArticleId IdType="pmc">PMC7871226</ArticleId><ArticleId IdType="pubmed">33547062</ArticleId></ArticleIdList></Reference><Reference><Citation>Carubbi F., Salvati L., Alunno A., Maggi F., Borghi E., Mariani R., Mai F., Paoloni M., Ferri C., Desideri G., et al. Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: Data from two Italian COVID-19 units. Sci. Rep. 2021;11:4863. doi: 10.1038/s41598-021-83831-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-83831-8</ArticleId><ArticleId IdType="pmc">PMC7921386</ArticleId><ArticleId IdType="pubmed">33649408</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancusi C., Grassi G., Borghi C., Ferri C., Muiesan M.L., Volpe M., Iaccarino G., SARS-RAS Investigator Group Clinical Characteristics and Outcomes of Patients with COVID-19 Infection: The Results of the SARS-RAS Study of the Italian Society of Hypertension. High Blood Press. Cardiovasc. Prev. 2021;28:5&#x2013;11. doi: 10.1007/s40292-020-00429-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40292-020-00429-3</ArticleId><ArticleId IdType="pmc">PMC7816058</ArticleId><ArticleId IdType="pubmed">33471297</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence  COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19.  [(accessed on 3 September 2021)].  Available online:  https://bit.ly/3BBHRip.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramadan M.S., Bertolino L., Marrazzo T., Florio M.T., Durante-Mangoni E. The Monaldi Hospital Cardiovascular Infection Study Group. Cardiac complications during the active phase of COVID-19: Review of the current evidence. Intern. Emerg. Med. 2021:1&#x2013;11. doi: 10.1007/s11739-021-02763-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-021-02763-3</ArticleId><ArticleId IdType="pmc">PMC8158084</ArticleId><ArticleId IdType="pubmed">34046852</ArticleId></ArticleIdList></Reference><Reference><Citation>Maleszewski J.J., Young P.M., Ackerman M.J., Halushka M.K. An urgent need for studies of the late effects of SARS-CoV-2 on the cardiovascular system. Circulation. 2021;143:1271e3. doi: 10.1161/CIRCULATIONAHA.120.051362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.051362</ArticleId><ArticleId IdType="pmc">PMC7996057</ArticleId><ArticleId IdType="pubmed">32969710</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Zhao P., Tang D., Zhu T., Han R., Zhan C., Liu W., Zeng H., Tao Q., Xia L. Cardiac Involvement in Patients Recovered from COVID-2019 Identified Using Magnetic Resonance Imaging. JACC Cardiovasc. Imaging. 2020;13:2330&#x2013;2339. doi: 10.1016/j.jcmg.2020.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.05.004</ArticleId><ArticleId IdType="pmc">PMC7214335</ArticleId><ArticleId IdType="pubmed">32763118</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha T., Knight D.S., Razvi Y., Kumar K., Vimalesvaran K., Thornton G., Patel R., Chacko L., Brown J.T., Coyle C., et al. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur. Heart J. 2021;42:1866&#x2013;1878. doi: 10.1093/eurheartj/ehab075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab075</ArticleId><ArticleId IdType="pmc">PMC7928984</ArticleId><ArticleId IdType="pubmed">33596594</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramadan M.S., Bertolino L., Zampino R., Durante-Mangoni E., Iossa D., Ursi M.P., D&#x2019;Amico F., Karruli A., Andini R., Bernardo M., et al. Cardiac sequelae after coronavirus disease 2019 recovery: A systematic review. Clin. Microbiol. Infect. 2021;27:1250&#x2013;1261. doi: 10.1016/j.cmi.2021.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.06.015</ArticleId><ArticleId IdType="pmc">PMC8220864</ArticleId><ArticleId IdType="pubmed">34171458</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall J., Myall K., Lam J.L., Mason T., Mukherjee B., West A., Dewar A. Identifying patients at risk of post-discharge complications related to COVID-19 infection. Thorax. 2021;76:408&#x2013;411. doi: 10.1136/thoraxjnl-2020-215861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215861</ArticleId><ArticleId IdType="pubmed">33542090</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixit N.M., Churchill A., Nsair A., Hsu J.J. Post-Acute COVID-19 Syndrome and the cardiovascular system: What is known? Am. Heart J. Plus. 2021;5:100025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8223036</ArticleId><ArticleId IdType="pubmed">34192289</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Working Group on the Clinical Characterisation and Management of COVID-19 Infection A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect. Dis. 2020;20:e192&#x2013;e197. doi: 10.1016/S1473-3099(20)30483-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30483-7</ArticleId><ArticleId IdType="pmc">PMC7292605</ArticleId><ArticleId IdType="pubmed">32539990</ArticleId></ArticleIdList></Reference><Reference><Citation>Adler Y., Charron P., Imazio M., Badano L., Bar&#xf3;n-Esquivias G., Bogaert J., Brucato A., Gueret P., Klingel K., Lionis C., et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS) Eur. Heart J. 2015;36:2921&#x2013;2964.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539677</ArticleId><ArticleId IdType="pubmed">26320112</ArticleId></ArticleIdList></Reference><Reference><Citation>Imazio M., Cecchi E., Demichelis B., Chinaglia A., Ierna S., Demarie D., Ghisio A., Pomari F., Belli R., Trinchero R. Myopericarditis versus viral or idiopathic acute pericarditis. Heart. 2007;94:498&#x2013;501. doi: 10.1136/hrt.2006.104067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/hrt.2006.104067</ArticleId><ArticleId IdType="pubmed">17575329</ArticleId></ArticleIdList></Reference><Reference><Citation>Imazio M., Bobbio M., Cecchi E., Demarie D., Demichelis B., Pomari F., Moratti M., Gaschino G., Giammaria M., Ghisio A., et al. Colchicine in addition to conventional therapy for acute pericarditis: Results of the COlchicine for acute PEricarditis (COPE) trial. Circulation. 2005;112:2012&#x2013;2016. doi: 10.1161/CIRCULATIONAHA.105.542738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.105.542738</ArticleId><ArticleId IdType="pubmed">16186437</ArticleId></ArticleIdList></Reference><Reference><Citation>Imazio M., Brucato A., Cemin R., Ferrua S., Maggiolini S., Beqaraj F., Demarie D., Forno D., Ferro S., Maestroni S., et al. A Randomized Trial of Colchicine for Acute Pericarditis. N. Engl. J. Med. 2013;369:1522&#x2013;1528. doi: 10.1056/NEJMoa1208536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1208536</ArticleId><ArticleId IdType="pubmed">23992557</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein A., Cremer P., Kontzias A., Furqan M., Tubman R., Roy M., Lim-Watson M.Z., Magestro M. US Database Study of Clinical Burden and Unmet Need in Recurrent Pericarditis. J. Am. Heart Assoc. 2021;10:e018950. doi: 10.1161/JAHA.120.018950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.018950</ArticleId><ArticleId IdType="pmc">PMC8475691</ArticleId><ArticleId IdType="pubmed">34284595</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwier N.C., Cornelio C.K., Epperson T.M. Managing acute and recurrent idiopathic pericarditis. J. Am. Acad. Physician Assist. 2020;33:16&#x2013;22. doi: 10.1097/01.JAA.0000615468.46936.6d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.JAA.0000615468.46936.6d</ArticleId><ArticleId IdType="pubmed">31880644</ArticleId></ArticleIdList></Reference><Reference><Citation>LeWinter M.M. Clinical practice. Acute pericarditis. N. Engl. J. Med. 2014;371:2410&#x2013;2416. doi: 10.1056/NEJMcp1404070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcp1404070</ArticleId><ArticleId IdType="pubmed">25517707</ArticleId></ArticleIdList></Reference><Reference><Citation>Imazio M., Demichelis B., Parrini I., Giuggia M., Cecchi E., Gaschino G., Demarie D., Ghisio A., Trinchero R. Day-hospital treatment of acute pericarditis: A management program for outpatient therapy. J. Am. Coll. Cardiol. 2004;43:1042&#x2013;1046. doi: 10.1016/j.jacc.2003.09.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2003.09.055</ArticleId><ArticleId IdType="pubmed">15028364</ArticleId></ArticleIdList></Reference><Reference><Citation>Maisch B., Rupp H., Risti&#x107; A., Pankuweit S. Pericardioscopy and epi- and pericardial biopsy&#x2014;A new window to the heart improving etiological diagnoses and permitting targeted intrapericardial therapy. Heart Fail. Rev. 2013;18:317&#x2013;328. doi: 10.1007/s10741-013-9382-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10741-013-9382-y</ArticleId><ArticleId IdType="pubmed">23479317</ArticleId></ArticleIdList></Reference><Reference><Citation>Pankuweit S., W&#xe4;dlich A., Meyer E., Portig I., Hufnagel G., Maisch B. Cytokine Activation in Pericardial Fluids in Different Forms of Pericarditis. Herz. 2000;25:748&#x2013;754. doi: 10.1007/PL00001993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/PL00001993</ArticleId><ArticleId IdType="pubmed">11200123</ArticleId></ArticleIdList></Reference><Reference><Citation>Risti&#x107; A.D., Pankuweit S., Maksimovi&#x107; R., Moosdorf R., Maisch B. Pericardial cytokines in neoplastic, autoreactive, and viral pericarditis. Heart Fail. Rev. 2012;18:345&#x2013;353. doi: 10.1007/s10741-012-9334-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10741-012-9334-y</ArticleId><ArticleId IdType="pubmed">22850905</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouriet F., Levy P.-Y., Casalta J.-P., Zandotti C., Collart F., Lepidi H., Cautela J., Bonnet J.L., Thuny F., Habib G., et al. Etiology of Pericarditis in a Prospective Cohort of 1162 Cases. Am. J. Med. 2015;128:784.e1&#x2013;784.e8. doi: 10.1016/j.amjmed.2015.01.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2015.01.040</ArticleId><ArticleId IdType="pubmed">25770033</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kr&#xfc;ger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271&#x2013;280.e8. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco-Melo D., Nilsson-Payant B.E., Liu W.C., Uhl S., Hoagland D., M&#xf8;ller R., Jordan T.X., Oishi K., Panis M., Sachs D., et al. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19. Cell. 2020;181:1036&#x2013;1045.e9. doi: 10.1016/j.cell.2020.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.026</ArticleId><ArticleId IdType="pmc">PMC7227586</ArticleId><ArticleId IdType="pubmed">32416070</ArticleId></ArticleIdList></Reference><Reference><Citation>Angeli F., Spanevello A., De Ponti R., Visca D., Marazzato J., Palmiotto G., Feci D., Reboldi G., Fabbri L.M., Verdecchia P. Electrocardiographic features of patients with COVID-19 pneumonia. Eur. J. Intern. Med. 2020;78:101&#x2013;106. doi: 10.1016/j.ejim.2020.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2020.06.015</ArticleId><ArticleId IdType="pmc">PMC7305928</ArticleId><ArticleId IdType="pubmed">32586646</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark D.E., Parikh A., Dendy J.M., Diamond A.B., George-Durrett K., Fish F.A., Slaughter J.C., Fitch W., Hughes S.G., Soslow J.H. COVID-19 Myocardial Pathology Evaluation in Athletes With Cardiac Magnetic Resonance (COMPETE CMR) Circulation. 2021;143:609&#x2013;612. doi: 10.1161/CIRCULATIONAHA.120.052573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.052573</ArticleId><ArticleId IdType="pmc">PMC7864610</ArticleId><ArticleId IdType="pubmed">33332151</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez M.W., Tucker A.M., Bloom O.J., Green G., DiFiori J.P., Solomon G., Phelan D., Kim J.H., Meeuwisse W., Sills A.K., et al. Prevalence of Inflammatory Heart Disease Among Professional Athletes With Prior COVID-19 Infection Who Received Systematic Return-to-Play Cardiac Screening. JAMA Cardiol. 2021;6:745. doi: 10.1001/jamacardio.2021.0565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.0565</ArticleId><ArticleId IdType="pmc">PMC7934073</ArticleId><ArticleId IdType="pubmed">33662103</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoffmann J., Shchendrygina A., Escher F., Vasa-Nicotera M., Zeiher A.M., et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawakami R., Sakamoto A., Kawai K., Gianatti A., Pellegrini D., Nasr A., Kutys B., Guo L., Cornelissen A., Mori M., et al. Pathological evidence for SARS-CoV-2 as a cause of myocarditis: JACC review topic of the week. J. Am. Coll. Cardiol. 2021;77:314&#x2013;325. doi: 10.1016/j.jacc.2020.11.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.11.031</ArticleId><ArticleId IdType="pmc">PMC7816957</ArticleId><ArticleId IdType="pubmed">33478655</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso C., Leone O., Rizzo S., De Gaspari M., Van Der Wal A.C., Aubry M.-C., Bois M.C., Lin P.T., Maleszewski J.J., Stone J.R. Pathological features of COVID-19-associated myocardial injury: A multicentre cardiovascular pathology study. Eur. Hear. J. 2020;41:3827&#x2013;3835. doi: 10.1093/eurheartj/ehaa664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa664</ArticleId><ArticleId IdType="pmc">PMC7543528</ArticleId><ArticleId IdType="pubmed">32968776</ArticleId></ArticleIdList></Reference><Reference><Citation>Imazio M., Spodick D.H., Brucato A., Trinchero R., Adler Y. Controversial Issues in the Management of Pericardial Diseases. Circulation. 2010;121:916&#x2013;928. doi: 10.1161/CIRCULATIONAHA.108.844753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.844753</ArticleId><ArticleId IdType="pubmed">20177006</ArticleId></ArticleIdList></Reference><Reference><Citation>Imazio M., Brucato A., Trinchero R., Shabetai R., Spodick D., Adler Y. Corticosteroid therapy for pericarditis: A double-edged sword. Nat. Clin. Pract. Neurol. 2008;5:118&#x2013;119. doi: 10.1038/ncpcardio1094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncpcardio1094</ArticleId><ArticleId IdType="pubmed">18212773</ArticleId></ArticleIdList></Reference><Reference><Citation>Imazio M., Brucato A., Lazaros G., Andreis A., Scarsi M., Klein A., De Ferrari G.M., Adler Y. Anti-inflammatory therapies for pericardial diseases in the COVID-19 pandemic: Safety and potentiality. J. Cardiovasc. Med. 2020;21:625&#x2013;629. doi: 10.2459/JCM.0000000000001059.</Citation><ArticleIdList><ArticleId IdType="doi">10.2459/JCM.0000000000001059</ArticleId><ArticleId IdType="pubmed">32658005</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M.W., Kim S.S., Lindsell C.J., Billig Rose E., Shapiro N.I., Files D.C., Gibbs K.W., Erickson H.L., Steingrub J.S., Smithline H.A., et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network&#x2014;United States, March&#x2013;June 2020. MMWR Morb. Mortal. Wkly. Rep. 2020;69:993&#x2013;998. doi: 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>UK Office for National Statistics  Prevalence of Long COVID Symptoms and COVID-19 Complications. 2020.  [(accessed on 3 September 2021)].  Available online:  https://bit.ly/3BwD8yg.</Citation></Reference><Reference><Citation>Kamal M., Abo Omirah M., Hussein A., Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int. J. Clin. Pract. 2020;75:e13746. doi: 10.1111/ijcp.13746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13746</ArticleId><ArticleId IdType="pmc">PMC7536922</ArticleId><ArticleId IdType="pubmed">32991035</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>